Stock screenerAll disclosures →
EDGAR →
APRE
Conviction 0HealthcareScan · Mon, Aug 10, 2026APRE$0.6549+0.71%
ResistanceSupportVol 14Vol MA14 53.73K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.6549
Change+0.71%
Gap+4.57%
Rel volume0.28×
Avg volume56.12K
Avg $ vol36.29K
SMA 200.6470
SMA 500.7173
SMA 2000.8735
Price vs 50-8.70%
Price vs 200-25.03%
MA stackbearish
50/200 cross—
Supertrenddown · 0.7721
RSI (14)47
MACD hist0.01
MACD crossbull · 2d
Stoch %K / %D59 / 48
ADX (14)28
+DI / −DI14 / 16
RSI divergence—
MACD divergence—
ATR %+8.22%
ADR %8.51%
52w high1.71
52w low0.5900
From 52w high-61.70%
Above 52w low+11.00%
New 52w highNo
SqueezeOn · 2d
Bollinger width21.83%
%B0.56
Donchian pos40.17%
Donchian high0.7514
Donchian low0.5901
AVWAP (52w high)0.9232
vs AVWAP high-29.06%
AVWAP (52w low)0.9041
vs AVWAP low-27.56%
OBV trendFlat
Chaikin MF (20)-0.19
Today vs 20d0.28×
Avg vol (14d)53.73K
Avg vol (20d)56.12K
Avg $ vol (20d)36.29K
Market cap8.11M
RS 3m (vs SPY)-31.86%
RS 6m (vs SPY)-9.97%
RS line new highNo
Trend template0/8
Technical rank25.4
1 week+9.57%
1 month-12.09%
3 months-33.17%
6 months-5.09%
1 year-60.31%
YTD-23.22%
P/E-0.64
P/B0.20
P/S—
P/FCF-0.63
EPS-1.93
Div yield—
ROE-30.30%
ROA-26.46%
Debt/Eq—
Current8.92
EV/EBITDA2.90
Gross margin—
Net margin—
Rev growth—
EPS growth2.77%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-38.36M
Revenue—
Net income-3.29M
Gross profit—
Free cash flow-12.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out12.38M
Employees8
ListedThu, Oct 3, 2019
Free float7.76M
Float %67.8%
Short interest60.59K
Days to cover0.8d
Short volume37.2%
Squeeze score6 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank25.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.8200
Support0.5950
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in APRE
No recent disclosed trades by Congress in APRE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in APRE · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Seizinger Bernd R. Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
Seizinger Bernd R. Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
Pamukcu Rifat Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
Pamukcu Rifat Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
Duey Marc Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
Duey Marc Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
BIZZARI JEAN-PIERRE Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
BIZZARI JEAN-PIERRE Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
HENNEMAN JOHN B III Director · Common Stock · 2026-06-16 | Grant | 3.13K | — | 2026-06-16 | 2026-06-17 |
HENNEMAN JOHN B III Director · Stock Options (Right to Buy) · 2026-06-16 | Grant | 12.55K | — | 2026-06-16 | 2026-06-17 |
SEC filings
EDGAR filings in APRE · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.